From material to tissue: Biomaterial development, scaffold fabrication, and tissue engineering

Dept. of Chemical and Biomolecular Engineering, Rice University, Houston, TX 77251
AIChE Journal (Impact Factor: 2.58). 10/2008; 54(12):3048 - 3067. DOI: 10.1002/aic.11610

ABSTRACT The need for techniques to facilitate the regeneration of failing or destroyed tissues remains great with the aging of the worldwide population and the continued incidence of trauma and diseases such as cancer. A 16-year history in biomaterial scaffold development and tissue engineering is examined, beginning with the synthesis of novel materials and fabrication of 3D porous scaffolds. Exploring cell-scaffold interactions and subsequently cellular delivery using biomaterial carriers, we have developed a variety of techniques for bone and cartilage engineering. In addition to delivering cells, we have utilized growth factors, DNA, and peptides to improve the in vitro and in vivo regeneration of tissues. This review covers important developments and discoveries within our laboratory, and the increasing breadth in the scope of our work within the expanding field of tissue engineering is presented. © 2008 American Institute of Chemical Engineers AIChE J, 2008

  • [Show abstract] [Hide abstract]
    ABSTRACT: Background Despite significant surgical advances over the last decades, segmental mandibular bone repair remains a challenge. In light of this, tissue engineering might offer a next step in the evolution of mandibular reconstruction. Purpose The purpose of the present report was to (1) systematically review preclinical in vivo as well as clinical literature regarding bone tissue engineering for mandibular continuity defects, and (2) to analyze their effectiveness. Materials and Methods An electronic search in the databases of the National Library of Medicine and ISI Web of Knowledge was carried out. Only publications in English were considered and the search was broadened to animals and humans. Furthermore, the reference lists of related review articles and publications selected for inclusion in this review were systematically screened. Results of histology data and amount of bone bridging were chosen as primary outcome variables. However, for human reports, clinical radiographic evidence was accepted for defined primary outcome variable. The biomechanical properties, scaffold degradation as well as clinical wound healing were selected as co- outcome variables. Results The electronic search in the databases of the National Library of Medicine and ISI Web of Knowledge resulted in the identification of 6727 and 5017 titles, respectively. Thereafter, title assessment and hand search resulted in 128 abstracts, 101 full-text articles and 29 scientific papers reporting on animal experiments as well as 11 papers presenting human data on the subject of tissue engineered reconstruction of mandibular continuity defects that could be included in the present review. Conclusions It was concluded that: (1) published preclinical in vivo as well as clinical data are limited, and (2) tissue engineered approaches demonstrate some clinical potential as an alternative to autogenous bone grafting.
    Tissue Engineering Part B Reviews 07/2013; · 4.64 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Cbfa1/Runx2 is a bone transcription factor homologous to the Drosophila protein, Runt. Runx2 is a master gene that encodes for a protein involved in the osteogenic differentiation process from mesenchymal precursors. It is known that in Cbfa1 deficient mice (Cbfa1(-/-)) the lack of mature osteoblasts is associated to incomplete bone mineralization. An important aim of modern biology is the development of new molecular tools for identification of therapeutic approaches. Recent discoveries in cell and molecular biology enabled researchers in the bone tissue-engineering field to develop new strategies for gene and cell-based therapies. This review summarizes the process of osteogenic differentiation from mesenchymal stem cells and the importance of bone regeneration is discussed. In particular, given the increasing interest in the study of the transcription factor Runx2, this review highlights the role of this target gene and addresses recent strategies using Runx2 for bone regeneration.
    Stem cell reviews 12/2011; 8(3):891-7. · 5.08 Impact Factor
  • Source
    Aortic Valve Surgery, 12/2011; , ISBN: 978-953-307-600-3


Available from